© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Corcept Therapeutics Incorporated (CORT) shows an Average True Range (ATR) of 6.16 and an Enterprise Value of 2.19B. Its average trading volume over the past 3 months is 1.16M, indicating liquidity. These fundamental metrics provide insight into CORT's underlying financial health and market activity.
Corcept Therapeutics Incorporated (CORT) technical indicators as of January 1, 2026: the SMA 20 is -56.91%, SMA 50 at -55.16%, and SMA 200 at -52.92%. The RSI 14 value is 14.83, suggesting its current momentum. These technical analysis signals help assess CORT's price trends and potential future movements.
Corcept Therapeutics Incorporated (CORT) stock performance overview as of January 1, 2026: The 52-week high is $117.33 (currently -70.34% below), and the 52-week low is $32.99 (currently -28.98% above). Over the past year, CORT's performance is -33.29%, compared to the S&P 500's 12.29% change.
According to market data, Corcept Therapeutics Incorporated (CORT) stock's recent performance metrics show that over the last month, CORT is -56.17%, with a Year-to-Date (YTD) performance of -30.94%. Over the past year, the stock has seen a -33.29% change. These figures summarize CORT's price movements across various periods, reflecting its historical returns.
According to current financial data, CORT stock's P/E (TTM) ratio is 33.74, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CORT, including P/S (4.86), P/B (5.62), and P/FCF (22.18), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.